Abbott’s Volt pulsed field ablation system — for the treatment of atrial fibrillation. The Volt system delivers high-energy electrical pulses to targeted areas of the heart to disrupt abnormal rhythms ...
The Columbus Regional Health Cardiac Catherization Lab Electrophysiology team, led by Dr. Albert Sey, is the first in Indiana to use the NuVision NAV ultrasound imaging catheter for AFib ablation ...
Former Chelsea manager Maurizio Sarri has undergone heart surgery after being diagnosed with a rhythm disorder, with reports ...
Columbus Regional Health Electrophysiology team completes 500th ablation case for treating irregular heartbeats ...
Abbott has announced the company has received approval from the U.S. Food and Drug Administration (FDA) for its Volt PFA ...
US FDA approves Abbott's Volt PFA System to treat patients with atrial fibrillation: Abbott Park, Illinois Wednesday, December 24, 2025, 12:00 Hrs [IST] Abbott, is a global health ...
The US Food and Drug Administration (FDA) has granted approval for Abbott’s Volt PFA System, expanding treatment options for ...
I felt fine, but my Whoop data told a different story. Paying attention led to early detection and a successful treatment.
After claiming its approval in Europe earlier this year, Abbott has secured the FDA’s go-ahead for its Volt pulsed field ablation system for irregular heart rhythms, a step forward in an | With the U.
Abbott (NYSE: ABT) announced today that the FDA approved its Volt pulsed field ablation (PFA) system to treat patients with AFib.
Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) has approved the company's Volt™ PFA System to treat patients battling atrial fibrillation (AFib). Abbott will soon begin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results